Hillsborough, NJ, United States of America

Shyam B Karki

This inventor holds 4 USPTO granted patents and 7 published patent applications. Top assignee: Biogen Ma Inc.. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shyam B Karki. Retrieved from https://idiyas.com/inventor/shyam-b-karki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: An Insight into the Innovations of Shyam B Karki

Introduction

Shyam B Karki is a notable inventor based in Hillsborough, NJ, who has made significant contributions to the field of pharmaceuticals. With a portfolio of four patents, Karki's innovations focus primarily on enhancing pharmaceutical compositions, particularly in the treatment of multiple sclerosis.

Latest Patents

Karki's latest patents include groundbreaking inventions related to dimethyl fumarate (DMF). One of his prominent patents describes DMF particles and pharmaceutical compositions thereof. This invention includes methods of preparing DMF particles, as well as DMF-coated particles featuring an enteric coating. Additionally, Karki has developed various dosage forms aimed at treating diseases and disorders such as multiple sclerosis.

Another significant patent details innovative pharmaceutical bead formulations comprising dimethyl fumarate. This invention presents novel compositions wherein an inert core is enveloped by a layer of dimethyl fumarate, topped with an enteric coating. The applications of these bead formulations demonstrate their potential benefits in the treatment of multiple sclerosis.

Career Highlights

Currently, Shyam B Karki is employed at Biogen MA Inc., a leading biotechnology firm focused on discovering, developing, and delivering innovative therapies for neurological diseases. His work at Biogen reflects his dedication to advancing pharmaceutical technologies and improving patient outcomes.

Collaborations

Throughout his career, Karki has collaborated with esteemed coworkers such as Cheuk-Yui Leung and Peter Zawaneh, contributing to a dynamic research environment that fosters innovation and creativity in drug development.

Conclusion

Shyam B Karki's contributions to pharmaceutical formulations, particularly concerning dimethyl fumarate, exemplify his innovative spirit and commitment to improving healthcare solutions. His work continues to make significant strides in treating conditions like multiple sclerosis, showcasing the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…